Trials / Completed
CompletedNCT04807322
Reverse Total Shoulder Arthroplasty in Patients Who Exceeded Their Life-expectancy: a Retrospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Bürgerspital Solothurn · Academic / Other
- Sex
- All
- Age
- 83 Years
- Healthy volunteers
- Accepted
Summary
Reverse total shoulder arthroplasty (RTSA) has become an established treatment for cuff arthropathy, severe osteoarthritis and in certain fracture cases. Due to the increasingly aging population, patients who have already exceeded their life-expectancy pose a significant challenge to the shoulder surgeon. Therefore, we wanted to investigate patient demographics, hospital stay length, complication rate functional outcome, patient reported outcome scores and mortality retrospectively for patients, who were older than 83 years at time of implantation of a RTSA.
Detailed description
This is a retrospective single institution study. All patients older than 83 years who received a reverse shoulder arthroplasty from 2008 until 2019 are included. Elective cases are compared to fracture cases (patient demographics, length of hospital stay, complication rate, functional outcome, patient reported outcome scores and mortality).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Reverse Total Shoulder Arthroplasty (RTSA) | Implantation of a Reverse Total Shoulder Arthroplasty |
Timeline
- Start date
- 2019-03-24
- Primary completion
- 2020-08-04
- Completion
- 2020-12-21
- First posted
- 2021-03-19
- Last updated
- 2021-03-19
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04807322. Inclusion in this directory is not an endorsement.